Integral Health Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-130,000	Closed	-$4.07M	–	77
2023 Q4	$4.07M	Buy	+130,000	New	+$4.07M	0.55%	58